In part 5, the conclusion of this Exclusive Interview, Dr. Swapnil N. Rajpathak talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about upcoming research studies on patient adherence.
Read More »Swapnil N. Rajpathak Part 4, ADA 2017 And Real World Study Guidelines
In part 4 of this Exclusive Interview, Dr. Swapnil N. Rajpathak talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about his interest in the comparative analysis of various drug classes and their real-world implications.
Read More »Swapnil Rajpathak Current Interview
Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2017 Scientific Sessions in San Diego, CA. Dr. Swapnil N. Rajpathak is the Executive Director of the Center for …
Read More »Yehuda Handelsman Current Interview
Yehuda Handelsman, MD, FACP, FACE, FNLA is an endocrinologist in private practice and Medical Director & Principal Investigator of the Metabolic Institute of America. He is a nationally and internationally recognized authority on Diabetes, Lipids, Obesity, HTN their and the prevention of cardiovascular disease.
Read More »Yehuda Handelsman Full Interview
In this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about safely lowering A1c, safe LDL, the life-saving efficiency of some very expensive drugs, and exciting diabetes technology.
Read More »Yehuda Handelsman Part 1, Interpreting Lipid Guidelines
In part 1 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the reasoning behind changes to cholesterol goals.
Read More »Yehuda Handelsman Part 2, Prescribing SGLT 2 Inhibitors
In part 2 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the actual cost to the lives of patients who are put on more expensive, but life-saving, diabetes drugs.
Read More »Yehuda Handelsman Part 3, Managing LDL of Patients
In part 3 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about his LDL recommendations according to the patient and varying health events.
Read More »Yehuda Handelsman Part 4, Safe A1C Levels for Diabetes Patients
In part 4 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about safely lowering patient A1c to their particular goal without hypoglycemia.
Read More »Yehuda Handelsman Part 5, CGM and the Future of Diabetes
In part 5 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the more exciting diabetes technology developments.
Read More »